| Absorption |
| Blood-Brain Barrier | BBB- | 0.6773 |
| Human Intestinal Absorption | HIA+ | 0.6527 |
| Caco-2 Permeability | Caco2- | 0.6758 |
| P-glycoprotein Substrate | Substrate | 0.6495 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8662 |
| Non-inhibitor | 0.8620 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9309 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6325 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7804 |
| CYP450 2D6 Substrate | Non-substrate | 0.9081 |
| CYP450 3A4 Substrate | Non-substrate | 0.6450 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7965 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9452 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9598 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9325 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8310 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8767 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9589 |
| Non-inhibitor | 0.8765 |
| AMES Toxicity | Non AMES toxic | 0.6536 |
| Carcinogens | Non-carcinogens | 0.9497 |
| Fish Toxicity | High FHMT | 0.9563 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9824 |
| Honey Bee Toxicity | High HBT | 0.6787 |
| Biodegradation | Not ready biodegradable | 0.8770 |
| Acute Oral Toxicity | III | 0.6807 |
| Carcinogenicity (Three-class) | Non-required | 0.5452 |